mannitol has been researched along with HIV Coinfection in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (38.89) | 18.2507 |
2000's | 7 (38.89) | 29.6817 |
2010's | 4 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Armstrong, AR; Chassany, O; Dolivo, M; Duracinsky, M; Leclercq, P; Mouly, F | 1 |
Chassany, O; Christen, MO; Dolivo, M; Duracinsky, M; Goujard, C; Herrmann, S; Leclercq, P | 1 |
Cheng, C; Cheng, J; Chi, Y; Hu, Z; Wei, H; Yang, Y | 1 |
Allers, K; Amasheh, M; Epple, HJ; Fromm, M; Kunkel, D; Loddenkemper, C; Moos, V; Schneider, T; Schulzke, JD; Troeger, H; Zeitz, M | 1 |
Ali, R; Jamil, B; Khan, A; Sultan, S | 1 |
Agrawal, L; Louboutin, JP; Reyes, BA; Strayer, DS; Van Bockstaele, EJ | 1 |
Aubertin, AM; Belliard, G; Desgranges, C; Hurtrel, B; Lafont, BA; Le Grand, R; Monceaux, V; Moreau, E; Muller, S; Roques, B | 1 |
Keni, SP; Sidle, DM | 1 |
Brignol, L; Chatelain, B; Meyer, C; Piquet, M; Rey, D; Ricbourg, B | 1 |
Kan, VL; Liappis, AP; Richman, NC; Simon, GL; Wong, B; Yoon, B | 1 |
Fleming, SC; Griffin, GE; Kapembwa, MS; Kynaston, JA; Laker, MF; Pearson, AD | 1 |
Bao, Y; Fox, JW; Guerrant, RL; Lima, AM; Silva, TM | 1 |
Fromm, M; Riecken, EO; Schmidt, W; Schmitz, H; Schulzke, JD; Stockmann, M | 1 |
Aussel, C; Bergmann, JF; Blondon, H; Dumitrescu, L; Giboudeau, J; Kodjo, A; Pernet, P; Randrianarisolo, MH; Vittecoq, D | 1 |
Duarte, CA; Dubed, M; Expósito, N; Gómez, CE; Lobaina, L; Navea, L; Soto, A | 1 |
Cano, CA | 1 |
Coutsoudis, A; Filteau, SM; Rollins, NC; Sullivan, KR; Tomkins, AM; Willumsen, JF | 1 |
Fleming, SC; Griffin, GE; Kapembwa, MS; Lucas, S; Moody, A; Serwadda, D; Sewankambo, N | 1 |
1 review(s) available for mannitol and HIV Coinfection
Article | Year |
---|---|
Sculptra (injectable poly-L-lactic acid).
Topics: Adipose Tissue; Atrophy; Cellulose; HIV Infections; Humans; Injections, Subcutaneous; Lactic Acid; Mannitol; Polymers; Skin Aging | 2007 |
2 trial(s) available for mannitol and HIV Coinfection
Article | Year |
---|---|
The multi-epitope polypeptide approach in HIV-1 vaccine development.
Topics: Adjuvants, Immunologic; AIDS Vaccines; Animals; Cuba; Cytotoxicity, Immunologic; Double-Blind Method; Epitopes; Genes, Synthetic; Haplorhini; HIV Antigens; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Immunization Schedule; Macaca fascicularis; Mannitol; Mice; Oleic Acids; Peptide Fragments; Rabbits; Recombinant Fusion Proteins; T-Lymphocytes, Cytotoxic; Vaccination; Vaccines, Synthetic | 1999 |
The effect of antenatal vitamin A and beta-carotene supplementation on gut integrity of infants of HIV-infected South African women.
Topics: Adult; beta Carotene; Cell Membrane Permeability; Dietary Supplements; Double-Blind Method; Female; HIV Infections; Humans; Infant; Infant, Newborn; Intestinal Mucosa; Lactulose; Mannitol; Nutritional Status; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; South Africa; Vitamin A | 2001 |
15 other study(ies) available for mannitol and HIV Coinfection
Article | Year |
---|---|
A longitudinal evaluation of the impact of a polylactic acid injection therapy on health related quality of life amongst HIV patients treated with anti-retroviral agents under real conditions of use.
Topics: Adult; Anti-Retroviral Agents; Cellulose; Face; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lactic Acid; Longitudinal Studies; Male; Mannitol; Middle Aged; Quality of Life | 2013 |
Safety of poly-L-lactic acid (New-Fill®) in the treatment of facial lipoatrophy: a large observational study among HIV-positive patients.
Topics: Adult; CD4 Lymphocyte Count; Cellulose; Face; Female; France; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lactic Acid; Longitudinal Studies; Male; Mannitol; Middle Aged; Polyesters; Polymers; United States | 2014 |
The use of mannitol in HIV-infected patients with symptomatic cryptococcal meningitis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Female; Headache; HIV Infections; Humans; Intracranial Pressure; Male; Mannitol; Meningitis, Cryptococcal; Middle Aged; Retrospective Studies; Seizures; Survival Analysis; Treatment Outcome; Young Adult | 2017 |
Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients.
Topics: Adult; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Apoptosis; Blotting, Western; Case-Control Studies; Cell Membrane Permeability; Claudin-1; Claudin-4; Claudins; Cytokines; Disease Progression; Duodenum; Electric Impedance; Epithelial Cells; Female; HIV Infections; Humans; Interleukin-13; Intestinal Absorption; Intestinal Mucosa; Male; Mannitol; Membrane Proteins; Middle Aged; Occludin; Rats; Rats, Wistar; Tight Junctions; Virus Replication | 2009 |
Tuberculous and cryptococcal meningitis in a setting with high TB and low HIV prevalence.
Topics: Amphotericin B; Anti-Bacterial Agents; Biomarkers; Cerebrospinal Fluid; Diuretics, Osmotic; Female; HIV Infections; Humans; Male; Mannitol; Meningitis, Cryptococcal; Middle Aged; Pakistan; Prevalence; Treatment Outcome; Tuberculosis; Tuberculosis, Meningeal | 2009 |
Intracisternal rSV40 administration provides effective pan-CNS transgene expression.
Topics: Animals; Apoptosis; Central Nervous System; Female; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Glutathione Peroxidase; HIV Envelope Protein gp120; HIV Infections; HIV-1; Immunohistochemistry; Mannitol; Neurons; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Sprague-Dawley; Simian virus 40; Superoxide Dismutase; Transgenes | 2012 |
Tat-neutralizing versus Tat-protecting antibodies in rhesus macaques vaccinated with Tat peptides.
Topics: Adjuvants, Immunologic; Administration, Intranasal; AIDS Vaccines; Animals; Antibody Formation; Cells, Cultured; Disease Models, Animal; Gene Products, tat; HIV Antibodies; HIV Infections; Injections, Intramuscular; Interferon-gamma; Interleukin-2; Leukocytes, Mononuclear; Macaca mulatta; Male; Mannitol; Neutralization Tests; Oleic Acids; tat Gene Products, Human Immunodeficiency Virus; Tumor Necrosis Factor-alpha; Vaccines, Subunit | 2005 |
[Polylactic acid injections: usefullness for the treatment of facial lipoatrophy in HIV+ patients under tritherapy].
Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Biocompatible Materials; Body Mass Index; Cellulose; Cosmetic Techniques; Esthetics; Face; Female; Follow-Up Studies; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Injections, Subcutaneous; Lactic Acid; Male; Mannitol; Middle Aged; Patient Satisfaction; Polymers; Prospective Studies; Treatment Outcome | 2007 |
Mannitol and inflammatory markers in the cerebral spinal fluid of HIV-infected patients with cryptococcal meningitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Biomarkers; Cerebrospinal Fluid; Cryptococcus; Cryptococcus neoformans; Female; HIV Infections; Humans; Inflammation; Male; Mannitol; Meningitis, Cryptococcal; Middle Aged | 2008 |
Analysis of multiple sugar probes in urine and plasma by high-performance anion-exchange chromatography with pulsed electrochemical detection. Application in the assessment of intestinal permeability in human immunodeficiency virus infection.
Topics: 3-O-Methylglucose; Adult; Carbohydrates; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Electrochemistry; Female; HIV Infections; Humans; Intestinal Absorption; Intestine, Small; Lactulose; Male; Mannitol; Methylglucosides; Permeability; Reproducibility of Results | 1993 |
Direct analysis of mannitol, lactulose and glucose in urine samples by high-performance anion-exchange chromatography with pulse amperometric detection. Clinical evaluation of intestinal permeability in human immunodeficiency virus infection.
Topics: Calibration; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Diarrhea; Glycosuria; HIV Infections; Humans; Intestinal Absorption; Lactulose; Mannitol; Sensitivity and Specificity | 1996 |
Duodenal biopsies of HIV-infected patients with diarrhoea exhibit epithelial barrier defects but no active secretion.
Topics: Adult; Aged; Biological Transport; Biopsy; Bumetanide; Chlorides; Diarrhea; Diuretics; Duodenum; Electric Impedance; Glucose; HIV Infections; Humans; In Vitro Techniques; Intestinal Mucosa; Lactulose; Malabsorption Syndromes; Mannitol; Middle Aged; Permeability; Phlorhizin; Sodium | 1998 |
Intestinal absorption and permeability in human immunodeficiency virus-infected patients.
Topics: Adult; Aged; Body Mass Index; CD4 Lymphocyte Count; Creatinine; Diarrhea; Female; HIV Infections; Humans; Intestinal Absorption; Intestinal Mucosa; Lactulose; Male; Mannitol; Middle Aged; Nutritional Status; Serum Albumin; Weight Loss; Xylose | 1999 |
The V3 loop based multi-epitope polypeptide TAB9 adjuvated with montanide ISA720 is highly immunogenic in nonhuman primates and induces neutralizing antibodies against five HIV-1 isolates.
Topics: Adjuvants, Immunologic; Amino Acid Sequence; Animals; Antibodies, Viral; Antibody Affinity; Consensus Sequence; Enzyme-Linked Immunosorbent Assay; HIV Infections; HIV-1; Immunodominant Epitopes; Macaca radiata; Mannitol; Molecular Sequence Data; Neutralization Tests; Oils; Oleic Acids; Peptides | 1999 |
Altered small-intestinal permeability associated with diarrhoea in human-immunodeficiency-virus-infected Caucasian and African subjects.
Topics: Adult; Animals; Black People; Cryptosporidium; Diarrhea; Feces; HIV Infections; Humans; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Lactulose; Male; Mannitol; Middle Aged; White People | 1991 |